When Two Worlds Collide: Navigating Diabetes in Cystic Fibrosis

  • 0Internal Medicine, Glangwili General Hospital, Carmarthen, GBR.

|

|

Summary

This summary is machine-generated.

Cystic fibrosis-related diabetes (CFRD) management primarily relies on insulin. Oral diabetes medications may be safe for select CFRD patients with stable organ function.

Area Of Science

  • Medical Genetics
  • Endocrinology
  • Pulmonology

Background

  • Cystic fibrosis (CF) is a genetic disorder caused by CFTR gene dysfunction, leading to thick mucus buildup and organ damage.
  • Diabetes mellitus is a metabolic disorder characterized by high blood sugar due to insulin issues.
  • Cystic fibrosis-related diabetes (CFRD) is a significant complication of CF.

Purpose Of The Study

  • To review treatment options for CFRD.
  • To analyze mechanisms of action, side effects, and patient impact of CFRD treatments.

Main Methods

  • This study is a narrative review of existing literature on CFRD treatments.

Main Results

  • Insulin is the primary treatment for CFRD.
  • Oral diabetes medications show potential safety and efficacy in specific CFRD patients.

Conclusions

  • Insulin remains the cornerstone for managing CFRD.
  • Oral medications are a viable option for selected CFRD patients with stable liver and lung function.

Related Concept Videos

Cystic Fibrosis: Management 01:24

229

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cystic Fibrosis: Pathogenesis 01:23

370

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Chronic Pancreatitis II: Collaborative Care 01:29

133

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...

Diabetes: Management and Pharmacotherapy 01:15

412

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications 01:15

715

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Diabetes Mellitus: Overview and Type I Subtype 01:22

3.3K

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...